Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	49,967	43,496	57,947	54,137	61,614	71,176
Market Cap Growth	-35.58%	-24.94%	7.04%	-12.13%	-13.43%	46.13%
Enterprise Value	35,316	31,551	48,198	44,338	52,552	59,031
Last Close Price	3550.00	3025.00	4030.00	3765.00	4285.00	4950.00
PE Ratio	12.58	10.54	17.91	23.21	11.12	152.01
PS Ratio	3.03	2.76	3.81	3.94	5.24	8.95
PB Ratio	1.42	1.23	1.85	1.88	2.28	3.32
P/TBV Ratio	1.43	1.23	1.85	1.88	2.29	3.34
P/FCF Ratio	18.62	15.49	29.41	244.98	-	-
P/OCF Ratio	15.96	14.19	20.34	24.36	453.15	1995.34
EV/Sales Ratio	2.14	2.00	3.17	3.22	4.47	7.42
EV/EBITDA Ratio	9.55	9.40	12.15	12.67	19.34	139.69
EV/EBIT Ratio	11.25	11.35	14.44	15.56	24.12	-
EV/FCF Ratio	13.16	11.24	24.47	200.64	-	-
Debt / Equity Ratio	0.08	0.08	0.15	0.15	0.16	0.05
Debt / EBITDA Ratio	0.79	0.88	1.18	1.25	1.63	2.67
Debt / FCF Ratio	1.09	1.06	2.37	19.82	-	-
Asset Turnover	0.39	0.37	0.39	0.39	0.39	0.32
Inventory Turnover	1.13	1.15	1.20	1.64	1.98	1.62
Quick Ratio	11.81	10.86	3.37	11.38	10.98	11.18
Current Ratio	14.70	13.49	4.12	14.67	12.97	13.07
Return on Equity (ROE)	12.07%	12.36%	10.76%	8.36%	22.87%	2.21%
Return on Assets (ROA)	4.53%	4.08%	5.36%	4.99%	4.54%	-0.63%
Return on Capital (ROIC)	5.20%	4.67%	6.03%	5.51%	5.04%	-0.71%
Return on Capital Employed (ROCE)	7.40%	6.60%	9.30%	8.00%	6.60%	-
Earnings Yield	8.12%	9.49%	5.58%	4.31%	8.99%	0.66%
FCF Yield	5.37%	6.46%	3.40%	0.41%	-5.15%	-0.08%
Buyback Yield / Dilution	0.18%	-	-	-	-38.26%	27.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.